Susann E.
- Country
- Germany
- Department
- Universitätskinderklinik Bereich Pädiatrische Endokrinologie und Stoffwechsel
Research Overview
- Evaluation of Safety, Tolerability, Pharmacokinetics, and Activity of Efpegerglucagon in Pediatric Patients with Congenital Hyperinsulinism
- An Operationally Seamless Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Enlicitide Decanoate in Pediatric Participants with Heterozygous Familial Hypercholesterolemia
Data & Insights
Has run more than one trial at 0 of 20 partner sites.
Specializations
Pediatric Endocrinology
This investigator specializes in the clinical evaluation of therapeutic interventions for Congenital Hyperinsulinism (CHI), a rare genetic condition affecting insulin regulation in children.
- Pediatric metabolic disorders
- Insulin dysregulation
- Genetic endocrine conditions
The investigator's work centers on advancing treatment options for young patients with metabolic disorders affecting blood glucose regulation.
Clinical Pharmacology
The investigator focuses on understanding pharmacokinetic profiles of novel therapeutic agents in pediatric populations with metabolic disorders.
- Drug safety assessment
- Therapeutic tolerability
- Pediatric drug development
Their expertise extends to evaluating medication safety and effectiveness in children with rare endocrine conditions.
Therapeutic Development
The investigator's research encompasses the evaluation of novel therapeutic compounds for rare pediatric endocrine disorders.
- Innovative treatment approaches
- Pediatric drug safety
- Clinical assessment methods
Their work contributes to the development of targeted treatments for genetic metabolic conditions affecting children.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.